BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
90.36
+2.57 (2.93%)
May 20, 2026, 4:00 PM EDT - Market closed
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $22.85 billion as of May 20, 2026. Its market cap has decreased by -5.98% in one year.
Market Cap
22.85B
Enterprise Value
7.40B
1-Year Change
-5.98%
Ranking
Category
Stock Price
$90.36
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $22.85B, an increase of 662.96%. That is a compound annual growth rate of 35.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 22.20B | -3.02% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 34.32B |
| Revolution Medicines | 31.96B |
| Royalty Pharma | 30.55B |
| Insmed | 23.39B |
| Roivant Sciences | 23.20B |
| Incyte | 19.39B |
| Moderna | 19.09B |
| Genmab | 16.45B |